Guangzhou Improve Med Instrument Tangible Net Worth Ratio
Guangzhou Improve Med Instrument tangible net worth ratio. Guangzhou Improve Med Instrument (300030) has a Tangible Net Worth Ratio of 95.1% as of March 2026. This metric is calculated by deducting intangible assets (CN¥32.86 Million) from net assets (CN¥677.10 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check how strategically is Guangzhou Improve Med Instrument's equity deployed to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Guangzhou Improve Med Instrument (2006–2025)
Tangible net worth ratio of Guangzhou Improve Med Instrument from 2006 to 2025. This chart shows how Guangzhou Improve Med Instrument's Tangible Net Worth Ratio has changed across 20 annual periods from 2006 to 2025. As of March 2026, the ratio stands at 95.1%, reflecting net assets of CN¥677.10 Million with intangible assets of CN¥32.86 Million CNY. See Guangzhou Improve Med Instrument (300030) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Guangzhou Improve Med Instrument Tangible Net Worth Ratio by Year (2006–2025)
Guangzhou Improve Med Instrument tangible net worth ratio by year from 2006 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Guangzhou Improve Med Instrument from 2006 to 2025, covering 20 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see 300030 company net worth.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 94.9% | CN¥655.10 Million | CN¥33.71 Million | CN¥1.03 Billion | ▲ +0.9 pp |
| 2024 | 94.0% | CN¥643.86 Million | CN¥38.64 Million | CN¥1.24 Billion | ▼ -0.2 pp |
| 2023 | 94.2% | CN¥762.33 Million | CN¥44.29 Million | CN¥1.43 Billion | ▲ +3.5 pp |
| 2022 | 90.7% | CN¥820.61 Million | CN¥76.22 Million | CN¥1.56 Billion | ▲ +2.5 pp |
| 2021 | 88.2% | CN¥1.03 Billion | CN¥121.51 Million | CN¥1.83 Billion | ▲ +1.7 pp |
| 2020 | 86.5% | CN¥1.00 Billion | CN¥135.05 Million | CN¥1.74 Billion | ▲ +4.6 pp |
| 2019 | 81.9% | CN¥838.26 Million | CN¥151.58 Million | CN¥1.51 Billion | ▲ +0.7 pp |
| 2018 | 81.3% | CN¥815.47 Million | CN¥152.80 Million | CN¥1.51 Billion | ▼ -3.6 pp |
| 2017 | 84.9% | CN¥963.72 Million | CN¥145.64 Million | CN¥1.75 Billion | ▼ -3.7 pp |
| 2016 | 88.6% | CN¥954.18 Million | CN¥109.10 Million | CN¥1.47 Billion | ▼ -0.5 pp |
| 2015 | 89.0% | CN¥930.46 Million | CN¥102.15 Million | CN¥1.44 Billion | ▼ -1.3 pp |
| 2014 | 90.3% | CN¥782.00 Million | CN¥75.52 Million | CN¥1.02 Billion | ▼ -1.8 pp |
| 2013 | 92.1% | CN¥772.70 Million | CN¥60.68 Million | CN¥883.08 Million | ▼ -2.7 pp |
| 2012 | 94.8% | CN¥687.93 Million | CN¥35.62 Million | CN¥766.53 Million | ▼ -3.0 pp |
| 2011 | 97.8% | CN¥648.25 Million | CN¥14.01 Million | CN¥716.72 Million | ▼ -0.5 pp |
| 2010 | 98.3% | CN¥592.55 Million | CN¥9.83 Million | CN¥651.24 Million | ▼ 0.0 pp |
| 2009 | 98.4% | CN¥563.53 Million | CN¥9.17 Million | CN¥657.84 Million | ▲ +10.0 pp |
| 2008 | 88.4% | CN¥78.73 Million | CN¥9.12 Million | CN¥141.69 Million | ▼ -0.7 pp |
| 2007 | 89.1% | CN¥58.27 Million | CN¥6.33 Million | CN¥73.88 Million | ▼ -3.6 pp |
| 2006 | 92.8% | CN¥19.33 Million | CN¥1.40 Million | CN¥39.95 Million | — |